Trends in adjuvant therapies after breast-conserving surgery for hormone receptor-positive ductal carcinoma in situ: findings from the National Cancer Database, 2004-2013.
Yasuaki SagaraRachel A FreedmanStephanie M WongFatih AydoganAnvy NguyenWilliam T BarryMehra GolshanPublished in: Breast cancer research and treatment (2017)
Our study suggests a shift in patterns of care for DCIS that is impacted by both clinicopathologic and demographic factors, with the use of RT decreasing and the use of ET increasing in HR-positive DCIS patients. Current trials are designed to address the possible over-treatment of low-risk DCIS.
Keyphrases
- end stage renal disease
- chronic kidney disease
- ejection fraction
- healthcare
- minimally invasive
- newly diagnosed
- early stage
- palliative care
- prognostic factors
- peritoneal dialysis
- quality improvement
- neoadjuvant chemotherapy
- coronary artery disease
- acute coronary syndrome
- replacement therapy
- combination therapy
- electronic health record
- locally advanced
- early breast cancer